Home » Topics » BioWorld Science

BioWorld Science
RSS

HLA-DPB1*05:01 allele predicts nonresponse to SLIT in allergic rhinitis

March 2, 2022

SIGLEC-6 targeting inhibits human mast cell degranulation and anaphylaxis

March 2, 2022

Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists

March 2, 2022

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

March 2, 2022

Spexis, University of Zurich describe new antimicrobial peptidomimetics

March 2, 2022

Antengene Discover, Shanghai Antengene present new serine/threonine-protein kinase ATR inhibitors

March 2, 2022

New HDAC6 inhibitors identified at Italfarmaco

March 2, 2022

SpFN_1B-06-PL vaccine induces durable immune response against pathogens

March 1, 2022

PBI-0451 shows promising results for the treatment of COVID-19

March 1, 2022

Tonix enters research agreement with Inserm to study oxytocin in Prader-Willi syndrome mouse model

March 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...